Phibro Animal Health's PAHC diversified product portfolio and wide presence in key growth areas bolster our confidence in the stock. The stock carries a Zacks Rank #2 (Buy). Phibro’s existing ...

Analyst Michael Ryskin from Bank of America Securities reiterated a Buy rating on Elanco Animal Health (ELAN – Research Report) and keeping the price target at $20.00. Michael Ryskin has given his Buy ...

Animal health products manufacturer Phibro Animal Health (NASDAQ:PAHC) in Q1 CY2026, with sales flat year on year at $347.8 million. On the other hand, the company’s outlook for the full year was ...

Phibro Animal Health PAHC shares have climbed 52.8% in a year, showcasing impressive momentum. The stock has outpaced the industry’s 14.3% growth and the S&P 500 composite’s 11.7% gain. With healthy ...

The stock price of Elanco (NYSE: ELAN), an animal health products company, saw a 20% fall on Thursday, June 27, after the company announced a delay in expected approval of two drugs. In comparison, ...

Phibro Animal Health delivers animal health and nutritional solutions through feed additives, vaccines, and performance products. The Zoetis acquisition added 37 product lines, driving a 24% increase ...

Ladies and gentlemen, thank you for standing by. Welcome, everyone, to the Elanco Animal Health first-quarter 2024 earnings conference call. At this time, all lines have been placed on mute to prevent ...

Private equity has embraced the pet sector over the last few years, as people increasingly see their furry friends as part of the family – with all the extra spending that implies. One area that’s ...

Fantastic. So everyone's still coming back from lunch. Apparently, the fried chicken was a huge hit is what I kept hearing around the hallway. So really looking forward to discussing food side of ...